What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[1] Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease
Hungin, A. Pali S.
Hill, Catherine
Molloy-Bland, Michael
Raghunath, Anan
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (02) : 109 - 116
[2] Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis
Nason, Katie S.
Wichienkuer, Promporn Paula
Awais, Omar
Schuchert, Matthew J.
Luketich, James D.
O'Rourke, Robert W.
Hunter, John G.
Morris, Cynthia D.
Jobe, Blair A.
ARCHIVES OF SURGERY, 2011, 146 (07) : 851 - 858
[3] Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease
Hungin, A. A.
Hill, Catherine
Bland, Michael V.
Raghunath, Anan
GASTROENTEROLOGY, 2011, 140 (05) : S583 - S583
[4] Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
Yadlapati, Rena
Delay, Kelli
MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 15 - +
[5] The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease
Pace, Fabio
Pace, Marina
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 423 - 427
[6] Clinical Significance of Gastroesophageal Reflux Disease and Proton Pump Inhibitor Use in Pulmonary Arterial Hypertension
Ramani, G.
Lam, D.
Park, M.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S309 - S309
[7] Proton Pump Inhibitor Prescriptions and Subsequent Use in US Veterans Diagnosed with Gastroesophageal Reflux Disease
Gawron, Andrew J.
Pandolfino, John E.
Miskevics, Scott
LaVela, Sherri L.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (07) : 930 - 937
[8] Proton Pump Inhibitor Prescriptions and Subsequent Use in US Veterans Diagnosed with Gastroesophageal Reflux Disease
Andrew J. Gawron
John E. Pandolfino
Scott Miskevics
Sherri L. LaVela
Journal of General Internal Medicine, 2013, 28 : 930 - 937
[9] What Factors Determine Whether a Gastroesophageal Reflux Disease Patient Will Respond to Proton Pump Inhibitor Therapy?
Nakada, Koji
Joh, Takashi
Higuchi, Kazuhide
Haruma, Ken
GASTROENTEROLOGY, 2013, 144 (05) : S856 - S856
[10] Proton pump inhibitor failure in gastro-oesophageal reflux disease - what about eosinophilic oesophagitis?
Sgouros, SN
Mantides, A
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1281 - 1281

← 1 2 3 4 5 →